Abstract
99P Bevacizumab plus erlotinib maintenance versus observation in advanced biliary tract cancers: Results from the phase II component of a prospective integrated phase II-phase III parallel design superiority clinical trial (BEER-BTC study)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have